Trial Profile
Boosting the pharmacokinetics of atazanavir with cobicistat
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Sep 2009
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Cobicistat (Primary) ; Ritonavir
- Indications HIV infections
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Gilead Sciences
- 14 Sep 2009 Results reported at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy.
- 13 Feb 2009 New trial record.